Phase
Condition
Rheumatoid Arthritis
Joint Injuries
Bone Diseases
Treatment
N/AClinical Study ID
Ages 18-65 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
Diagnosis of adult onset RA (functional class I-III) for at least 6 months
Must have been treated with and be tolerating Methotrexate (5-25 mg/week) for 3months, at a stable dose for at least 4 weeks
Must have at least 4 swollen and tender joints due to rheumatoid arthritis
Exclusion
Exclusion Criteria:
History of recurrent infections requiring antibiotic treatment within 12 months
Serious local infection or systemic infection within 3 months
Suffering from rheumatic or autoimmune disease other than RA
History of cancer, heart failure, kidney disease, liver disease, HIV infection,tuberculosis or other serious illness
Study Design
Connect with a study center
Research Centre
Moscow,
Russian FederationSite Not Available
Research Centre
Yaroslavl,
Russian FederationSite Not Available
Research Site
Anniston, Alabama
United StatesSite Not Available
Research Centre
Palm Desert, California
United StatesSite Not Available
Research Site
Oklahoma City, Oklahoma
United StatesSite Not Available
Research Centre
Duncansville, Pennsylvania
United StatesSite Not Available

Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.